Cargando…

NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential

Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobioti...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Na, Zhang, Lu, Gao, Wei, Huang, Canhua, Huber, Peter Ernst, Zhou, Xiaobo, Li, Changlong, Shen, Guobo, Zou, Bingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539288/
https://www.ncbi.nlm.nih.gov/pubmed/33028824
http://dx.doi.org/10.1038/s41392-020-00311-7
_version_ 1783591029020033024
author Xie, Na
Zhang, Lu
Gao, Wei
Huang, Canhua
Huber, Peter Ernst
Zhou, Xiaobo
Li, Changlong
Shen, Guobo
Zou, Bingwen
author_facet Xie, Na
Zhang, Lu
Gao, Wei
Huang, Canhua
Huber, Peter Ernst
Zhou, Xiaobo
Li, Changlong
Shen, Guobo
Zou, Bingwen
author_sort Xie, Na
collection PubMed
description Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobiotics. These effects are mainly achieved by the driving effect of NAD(+) on metabolic pathways as enzyme cofactors transferring hydrogen in oxidation-reduction reactions. Besides, multiple NAD(+)-dependent enzymes are involved in physiology either by post-synthesis chemical modification of DNA, RNA and proteins, or releasing second messenger cyclic ADP-ribose (cADPR) and NAADP(+). Prolonged disequilibrium of NAD(+) metabolism disturbs the physiological functions, resulting in diseases including metabolic diseases, cancer, aging and neurodegeneration disorder. In this review, we summarize recent advances in our understanding of the molecular mechanisms of NAD(+)-regulated physiological responses to stresses, the contribution of NAD(+) deficiency to various diseases via manipulating cellular communication networks and the potential new avenues for therapeutic intervention.
format Online
Article
Text
id pubmed-7539288
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-75392882020-10-07 NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential Xie, Na Zhang, Lu Gao, Wei Huang, Canhua Huber, Peter Ernst Zhou, Xiaobo Li, Changlong Shen, Guobo Zou, Bingwen Signal Transduct Target Ther Review Article Nicotinamide adenine dinucleotide (NAD(+)) and its metabolites function as critical regulators to maintain physiologic processes, enabling the plastic cells to adapt to environmental changes including nutrient perturbation, genotoxic factors, circadian disorder, infection, inflammation and xenobiotics. These effects are mainly achieved by the driving effect of NAD(+) on metabolic pathways as enzyme cofactors transferring hydrogen in oxidation-reduction reactions. Besides, multiple NAD(+)-dependent enzymes are involved in physiology either by post-synthesis chemical modification of DNA, RNA and proteins, or releasing second messenger cyclic ADP-ribose (cADPR) and NAADP(+). Prolonged disequilibrium of NAD(+) metabolism disturbs the physiological functions, resulting in diseases including metabolic diseases, cancer, aging and neurodegeneration disorder. In this review, we summarize recent advances in our understanding of the molecular mechanisms of NAD(+)-regulated physiological responses to stresses, the contribution of NAD(+) deficiency to various diseases via manipulating cellular communication networks and the potential new avenues for therapeutic intervention. Nature Publishing Group UK 2020-10-07 /pmc/articles/PMC7539288/ /pubmed/33028824 http://dx.doi.org/10.1038/s41392-020-00311-7 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Xie, Na
Zhang, Lu
Gao, Wei
Huang, Canhua
Huber, Peter Ernst
Zhou, Xiaobo
Li, Changlong
Shen, Guobo
Zou, Bingwen
NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title_full NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title_fullStr NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title_full_unstemmed NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title_short NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
title_sort nad(+) metabolism: pathophysiologic mechanisms and therapeutic potential
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539288/
https://www.ncbi.nlm.nih.gov/pubmed/33028824
http://dx.doi.org/10.1038/s41392-020-00311-7
work_keys_str_mv AT xiena nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT zhanglu nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT gaowei nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT huangcanhua nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT huberpeterernst nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT zhouxiaobo nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT lichanglong nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT shenguobo nadmetabolismpathophysiologicmechanismsandtherapeuticpotential
AT zoubingwen nadmetabolismpathophysiologicmechanismsandtherapeuticpotential